[Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
D000818:Animals; D000904:Antibiotics, Antitubercular / Q000494:pharmacology*; D002207:Capreomycin / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004776:Enviomycin / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D010303:Paromomycin / Q000031:analogs & derivatives / Q000494:pharmacology; D014756:Viomycin / Q000494:pharmacology
D000904:Antibiotics, Antitubercular; D002207:Capreomycin; D007612:Kanamycin; D010303:Paromomycin; D004776:Enviomycin; D014756:Viomycin